INTERVIEW: ASEAN Preps For First Dengue Vaccine
This article was originally published in PharmAsia News
As the first vaccine against the dengue virus moves towards initial regulatory filings, experts have met in Asia to consider the potential impact of the product and issues related to its availability.
You may also be interested in...
In line with similar initiatives by Japan on other regulatory fronts, the country's Agency for Medical Research and Development is building up its partnerships and presence in Asia.
Asia Deal Watch: RAPT And Hanmi Partner On CCR4 Antagonist Offering Potential In Multiple Cancer Types
RAPT can earn up to $108m in milestones plus sales royalties under the deal. BerGenBio, Piramal partner on developing AML therapy.
Japanese company starts pivotal trial with novel molecule as it looks to build oncology presence.